![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | |
C07K 16/28 | |||
A61K 35/74 | |||
A61P 35/00 |
(11) | Number of the document | 3319635 |
(13) | Kind of document | T |
(96) | European patent application number | 16734013.2 |
Date of filing the European patent application | 2016-06-24 | |
(97) | Date of publication of the European application | 2018-05-16 |
(45) | Date of publication and mention of the grant of the patent | 2021-04-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2016/051893 |
Date | 2016-06-24 |
(87) | Number | WO 2016/207646 |
Date | 2016-12-29 |
(30) | Number | Date | Country code |
201511120 | 2015-06-24 | GB | |
201511121 | 2015-06-24 | GB |
(72) |
AKLE, Charles, GB
BRUNET, Laura Rosa, GB
|
(73) |
Immodulon Therapeutics Limited,
6-9 The Square Stockley Park, Uxbridge UB11 1FW,
GB
|
(54) | A CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY |
A CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY |